Accuray (ARAY) Cash & Equivalents Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Accuray | 47,295.88 | -38.49 Mn | 25.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 58.45% |
| Dec 31, 2025 | -17.38% |
| Sep 30, 2025 | -6.77% |
| Jun 30, 2025 | -11.80% |
| Mar 31, 2025 | -59.21% |
| Dec 31, 2024 | 88.24% |
| Sep 30, 2024 | -64.06% |
| Jun 30, 2024 | 46.34% |
| Mar 31, 2024 | 95.75% |
| Dec 31, 2023 | -61.77% |
| Sep 30, 2023 | -62.27% |
| Jun 30, 2023 | 55.51% |
| Mar 31, 2023 | 116.32% |
| Dec 31, 2022 | -3.16% |
| Sep 30, 2022 | -68.73% |
| Jun 30, 2022 | -68.94% |
| Mar 31, 2022 | -67.90% |
| Dec 31, 2021 | -12.29% |
| Sep 30, 2021 | -63.35% |
| Jun 30, 2021 | -65.80% |
| Mar 31, 2021 | 28.68% |
| Dec 31, 2020 | 3.94% |
| Sep 30, 2020 | 1.00% |
| Jun 30, 2020 | 6.22% |
| Mar 31, 2020 | -1.23% |
| Dec 31, 2019 | -51.36% |
| Sep 30, 2019 | -5.49% |
| Jun 30, 2019 | -36.02% |
| Mar 31, 2019 | -52.61% |
| Dec 31, 2018 | -3.34% |
| Sep 30, 2018 | 1.88% |
| Jun 30, 2018 | -33.09% |
| Mar 31, 2018 | -59.91% |
| Dec 31, 2017 | -3.45% |
| Sep 30, 2017 | -11.03% |
| Jun 30, 2017 | -13.25% |
| Mar 31, 2017 | -16.84% |
| Dec 31, 2016 | -68.37% |
| Sep 30, 2016 | -9.81% |
| Jun 30, 2016 | 4.54% |
| Mar 31, 2016 | -54.81% |
| Dec 31, 2015 | 12.30% |
| Sep 30, 2015 | 15.00% |
| Jun 30, 2015 | 11.85% |